This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (81)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

A Controlled Study

Wilma M. Harrison, MD; Jean Endicott, PhD; John Nee, PhD

Arch Gen Psychiatry. 1990;47(3):270-275.

Abstract
• Thirty women who met DSM-III-R criteria for late luteal phase dysphoric disorder completed a double-blind, randomly assigned crossover treatment study comparing alprazolam with placebo. Alprazolam was found to be superior to placebo. The outcome measures included physicians' global ratings as well as patients' prospective (daily) ratings and retrospective assessments. Improved study design, which addressed methodologic flaws of most previous studies of treatment outcome of "premenstrual syndrome" may account, in part, for our ability to demonstrate significant drug/placebo differences. This includes extensive screening to eliminate women who had premenstrual exacerbations of a more persistent mental illness rather than a discrete premenstrual disorder, use of prospective ratings to confirm retrospective reports of symptom patterns, placebo washout before randomization, and use of patients as their own controls.

Author Affiliations
From the New York State Psychiatric Institute and the Department of Psychiatry, Columbia University, College of Physicians and Surgeons, New York.

Footnotes
Accepted for publication March 10, 1989.

Reprint requests to Box 123, 722 W 168th St, New York, NY 10032 (Dr Harrison).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Management Strategies for Premenstrual Syndrome/Premenstrual Dysphoric Disorder
Jarvis et al.
The Annals of Pharmacotherapy 2008;42:967-978.
ABSTRACT | FULL TEXT  

Using Patients As Their Own Controls for Cost Evaluation of Phase I Clinical Trials
Sherman et al.
JCO 2004;22:1308-1314.
ABSTRACT | FULL TEXT  

Premenstrual Dysphoric Disorder
Grady-Weliky
NEJM 2003;348:433-438.
FULL TEXT  

Luteal Phase Sertraline Treatment for Premenstrual Dysphoric Disorder: Results of a Double-blind, Placebo-Controlled, Crossover Study
Jermain et al.
Arch Fam Med 1999;8:328-332.
ABSTRACT | FULL TEXT  

A 45-Year-Old Woman With Premenstrual Dysphoric Disorder
Parry
JAMA 1999;281:368-373.
FULL TEXT  

Symptomatic Improvement of Premenstrual Dysphoric Disorder With Sertraline Treatment: A Randomized Controlled Trial
Yonkers et al.
JAMA 1997;278:983-988.
ABSTRACT  

A Double-blind Trial of Oral Progesterone, Alprazolam, and Placebo in Treatment of Severe Premenstrual Syndrome
Freeman et al.
JAMA 1995;274:51-57.
ABSTRACT  

Fluoxetine in the Treatment of Premenstrual Dysphoria
Steiner et al.
NEJM 1995;332:1529-1534.
ABSTRACT | FULL TEXT  

Alprazolam in the Treatment of Premenstrual Syndrome: A Double-blind, Placebo-Controlled Trial
Schmidt et al.
Arch Gen Psychiatry 1993;50:467-473.
ABSTRACT